The presence of psoriasis, metabolic syndrome and their combination increases the serum levels of crp and cd5l but not scd200r1 and stlr2 in participants

HIGHLIGHTS

• who: Drahomira Holmannova and collaborators from the Institute of Preventive Medicine, Faculty of Medicine in, Charles University have published the paper: The Presence of Psoriasis, Metabolic Syndrome and Their Combination Increases the Serum Levels of CRP and CD5L but Not sCD200R1 and sTLR2 in Participants, in the Journal: (JOURNAL)
• what: The authors measured inflammatory and anti-inflammatory markers associated with psoriasis and the metabolic syndromes sTLR2, CD5L, and sCD200R1, the levels of which have not been evaluated yet.
• how: The study was conducted in accordance with the Declaration of Helsinki and the protocol . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.